Sclerotic and retracted supravenous hyperpigmentation associated with combination chemotherapy for metastatic breast carcinoma.
Chen
G-Y
GY
Lee
J Y-Y
JY
Chen
W-C
WC
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D001808:Blood Vessels / Q000187:drug effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage; D015251:Epirubicin / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D017495:Hyperpigmentation / Q000139:chemically induced*; D007262:Infusions, Intravenous; D008875:Middle Aged
D015251:Epirubicin; D003520:Cyclophosphamide; D005472:Fluorouracil